EXOZYMES INC. Proceeds from (Repayments of) Related Party Debt
EXOZYMES INC. (EXOZ) reported Proceeds from (Repayments of) Related Party Debt of -$43.25 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2026-05-14
- EXOZYMES INC. proceeds from (repayments of) related party debt for the quarter ending 2025-03-31 was -$43.25K.
- EXOZYMES INC. proceeds from (repayments of) related party debt for the quarter ending 2024-12-31 was $754.79K.
- EXOZYMES INC. proceeds from (repayments of) related party debt for the quarter ending 2024-09-30 was $582.07K.
- EXOZYMES INC. proceeds from (repayments of) related party debt for fiscal 2024 was $3.98M.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$43.25K 10-Q · filed 2026-05-14 | $711.54K derived: sum of 2 quarters · filed 2026-05-14 | $1.29M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $754.79K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.34M derived: sum of 2 quarters · filed 2026-03-30 | $3.98M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $582.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.22M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $2.64M 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |